Evidence map›Paper›PMID 33854097›Full record

ArticleScientific reports2021

Validation of a biomarker tool capable of measuring the absorbed dose soon after exposure to ionizing radiation.

Anna Giovanetti, Raffaella Marconi, Noha Awad, Hala Abuzied, Neveen Agamy, Mohamed Barakat, Cecilia Bartoleschi, Gianluca Bossi, Marco Canfora, Amr A Elsaid and 11 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 2 countries.

Anna GiovanettiDivision of Health Protection Technologies, ENEA-Italian National Agency for New Technologies, Energy and Sustainable Economic Development, 00123, Rome, Italy. anna.giovanetti@enea.it.
Raffaella MarconiScientific Direction, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, 00149, Rome, Italy.
Noha AwadEpidemiology Department, High Institute of Public Health, Alexandria University, Alexandria, 21561, Egypt.
Hala AbuziedAlexandria University Cancer Research Cluster, Alexandria, 21561, Egypt.
Neveen AgamyNutrition Department, High Institute of Public Health, Alexandria University, Alexandria, 21561, Egypt.
Mohamed BarakatAlexandria University Cancer Research Cluster, Alexandria, 21561, Egypt.
Cecilia BartoleschiDivision of Health Protection Technologies, ENEA-Italian National Agency for New Technologies, Energy and Sustainable Economic Development, 00123, Rome, Italy.
Gianluca BossiOncogenomic and Epigenetic Unit, Department of Diagnostic Research and Technological Innovation, IRCCS - Regina Elena National Cancer Institute, 00144, Rome, Italy.
Marco CanforaClinical Trial Center, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, 00144, Rome, Italy.
Amr A ElsaidOncology Department, Faculty of Medicine, Alexandria University, Alexandria, 21561, Egypt.
Laura IoannilliDepartment of Biology, University of Rome "Tor Vergata", 00133, Rome, Italy.
Horeya M IsmailAlexandria University Cancer Research Cluster, Alexandria, 21561, Egypt.
Yasmine Amr IssaMedical Biochemistry Department, Faculty of Medicine, University of Alexandria, Alexandria, 21561, Egypt.
Flavia NovelliDivision of Health Protection Technologies, ENEA-Italian National Agency for New Technologies, Energy and Sustainable Economic Development, 00123, Rome, Italy.
Maria Chiara PardiniDivision of Health Protection Technologies, ENEA-Italian National Agency for New Technologies, Energy and Sustainable Economic Development, 00123, Rome, Italy.
Claudio PioliDivision of Health Protection Technologies, ENEA-Italian National Agency for New Technologies, Energy and Sustainable Economic Development, 00123, Rome, Italy.
Paola PinnaròDepartments of Radiation Oncology, IRCCS - Regina Elena National Cancer Institute, 00144, Rome, Italy.
Giuseppe SanguinetiDepartments of Radiation Oncology, IRCCS - Regina Elena National Cancer Institute, 00144, Rome, Italy.
Mohamed M TahounEpidemiology Department, High Institute of Public Health, Alexandria University, Alexandria, 21561, Egypt.
Riccardo TurchiDepartment of Biology, University of Rome "Tor Vergata", 00133, Rome, Italy.
Lidia StrigariIRCCS Azienda Ospedaliera Universitaria di Bologna, 40138, Bologna, Italy.
Alexandria University · EGNational Agency for New Technologies, Energy and Sustainable Economic Development · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Rome Tor Vergata · ITAzienda USL di Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A radiological or nuclear attack could involve such a large number of subjects as to overwhelm the emergency facilities in charge. Resources should therefore be focused on those subjects needing immediate medical attention and care. In such a scenario, for the triage management by first responders, it is necessary to count on efficient biological dosimetry tools capable of early detection of the absorbed dose. At present the validated assays for measuring the absorbed dose are dicentric chromosomes and micronuclei counts, which require more than 2-3 days to obtain results. To overcome this limitation the NATO SPS Programme funded an Italian-Egyptian collaborative project aimed at validating a fast, accurate and feasible tool for assessing the absorbed dose early after radiation exposure. Biomarkers as complete blood cell counts, DNA breaks and radio-inducible proteins were investigated on blood samples collected before and 3 h after the first fraction of radiotherapy in patients treated in specific target areas with doses/fraction of about: 2, 3.5 or > 5 Gy and compared with the reference micronuclei count. Based on univariate and multivariate multiple linear regression correlation, our results identify five early biomarkers potentially useful for detecting the extent of the absorbed dose 3 h after the exposure.

Indexed as

Radiation, IonizingAdultAgedAged, 80 and overArea Under CurveBiomarkersBlood Cell CountDNA Breaks, Double-StrandedDose-Response Relationship, RadiationFemaleHumansMaleMiddle AgedRadiation ExposureRadiometryROC CurveBiomarkers

Identifiers

PMID33854097
PMCPMC8047015
OpenAlexW3155796925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.